White Paper: The Treatment of Schizophrenia and Bipolar Disorder
|
|
- Ruth Strickland
- 6 years ago
- Views:
Transcription
1 White Paper: The Treatment of Schizophrenia and Bipolar Disorder in Children: What is Medically Necessary? For Health Plans, Medical Management Organizations and TPAs Trends in the Diagnosis and Treatment of Pediatric Bipolar Disorder and Schizophrenia According to one study s estimates, the diagnosis of bipolar disorder in children grew by 40-fold between and Many of these children exhibited a pattern not consistent with a bipolar diagnosis. Speci cally, bipolar disorder involves episodes of mania, which can show up in children as irritability. However, many of the children diagnosed did not have clear-cut episodes of irritability; instead, they were constantly irritable. Some experts believe that many children are being misdiagnosed. Bipolar disorder has become a controversial diagnosis in children. Diagnosis in young children is di!cult, especially since many of the symptoms are similar to those of attention de cit hyperactivity disorder (ADHD) or conduct disorders. Overdiagnosis of bipolar disorder results in unnecessary use of medications, which are often associated with serious side e"ects. On the other hand, underdiagnosis can be harmful as well if children remain untreated. Early-onset schizophrenia (onset before adulthood) is a rare, severe, and chronic form of schizophrenia. When it is diagnosed in young children, it results in long-term use of antipsychotic medication as a mainstay of treatment, along with psychotherapeutic intervention. Increasingly, e"orts are being made toward early detection and management of prodromal symptoms, which may make it possible to implement early preventative and treatment strategies before the onset of the syndromal illness. The use of medication at the prodromal stage, however, presents clinical and ethical challenges. Clinical Characteristics of Bipolar Disorder and Schizophrenia Bipolar Disorder Diagnosis in young children is di cult, especially since many of the symptoms are similar to those of ADHD or conduct disorders. The exact symptoms of bipolar disorder vary from person to person. For some people, depression causes the most problems; for others, manic symptoms are the main concern. Symptoms of depression and mania may also occur together. The manic phase of bipolar disorder can include severe changes in mood. Individuals may either be unusually happy or silly, or be very irritable, angry, agitated, or aggressive. Patients may also have unrealistic highs in self-esteem. For example, a teenager may feel all-powerful or like a superhero with special powers. Some patients may experience a great increase in energy and the ability to go with little or no sleep for days without feeling tired. Other manic symptoms of bipolar disorder include an increase in talking (talking too much or too fast, changing topics too quickly, and cannot be interrupted), distractibility (attention moves constantly from one thing to the next), and repeated high-risk-taking behavior (abusing alcohol and drugs, reckless driving, or sexual promiscuity). Depressive symptoms of bipolar disorder include irritability, depressed mood, persistent sadness, frequent crying, thoughts of death or suicide, and loss of enjoyment in favorite activities. Patients may also have frequent complaints of physical illnesses (such as headaches or stomach aches), or even boredom. Other depressive symptoms may include low energy level, fatigue, poor concentration, and major changes in eating or sleeping patterns. The fth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for bipolar disorder do not distinguish adult-onset from childhood- or adolescent-onset symptoms of bipolar disorder. The diagnostic criteria for bipolar disorder are the same regardless of the patient s age at the onset of symptoms. Despite clinically important di"erences in the way mood disorders, particularly behavioral di"erences manifest in a child or an adolescent, no diagnostic accommodations have yet been made on the basis of age. The criteria require a distinct period of elevated, expansive, or irritable mood and abnormally and persistently increased goal-directed activity or energy that lasts at least one week AllMed Healthcare Management Inc. 1
2 and presents most of the day, nearly every day in which three or more of the following are present (four if mood is only irritable): In#ated self-esteem or grandiosity Deacresed need for sleep More talkative, pressured speech Flight of ideas or racing thoughts Increased distractibility Increased goal-directed activity (psychomotor agitation) Involvement with pleasurable behaviors with the potential for painful consequences Schizophrenia The earliest indications of childhood schizophrenia may include developmental problems, such as language delays, late or unusual crawling, late walking, and other abnormal motor behaviors (such as rocking or arm #apping). Some of these signs and symptoms are also common in children with pervasive developmental disorders, such as autism. Ruling out these developmental disorders is one of the rst steps in diagnosing childhood schizophrenia. As children with schizophrenia age, more typical signs and symptoms of the disorder begin to appear, including: Seeing things and hearing voices that are not real (hallucinations) Odd and ecentric behavior and/or speech Unusual or bizarre thoughts and ideas Confusing television and dreams for reality Confused thinking Extreme moodiness Ideas that people are out to get them or talking about them (paranoia) Severe anxiety and fearfulness Di!culty relating to peers, and keeping friends Withdrawn and increased isolation Worsening personal grooming The DSM-V criteria for schizophrenia require two (or more) of the following, each present for a signi cant portion of time during a one-month period, or less if successfully treated (at least one of these should include 1-3): 1. Delusions 2. Hallucinations 3. Disorganized Speech 4. Grossly disorganized or catatonic behavior 5. Negative symptoms (i.e., diminished emotional expression or avolition) Pharmacologic Treatment Options Bipolar Disorder Medications Mood stabilizers, such as lithium carbonate, sodium divalproex, and carbamazepine, have traditionally been the mainstays of treatment of patients with bipolar disorder. They are indicated for control of manic episodes occurring in bipolar disorder. Lithium is considered a rst-line agent for long-term prophylaxis in bipolar illness. 2
3 Anticonvulsants have been e"ective in preventing mood swings associated with bipolar disorder. Valproic acid has proven e"ectiveness in treating and preventing mania. It is classi ed as a mood stabilizer and can be used alone or in combination with lithium. It is useful in treating rapid-cycling bipolar disorders and has been used to treat aggressive or behavioral disorders. Carbamazepine is e"ective in cases that do not respond to lithium therapy. It has been e"ective in treating rapid-cycling bipolar disorder. Atypical antipsychotics are increasingly used in bipolar disorder, with or without psychotic symptoms. This class of medications includes risperidone, quetiapine, olanzapine, aripiprazole, ziprasidone, and clozapine. In addition, benzodiazepines may be used to improve sleep and to modulate agitation during hospitalization. Schizophrenia Medications Atypical antipsychotics, such as aripiprazole, risperidone, quetiapine, olanzapine, and ziprasidone, are generally chosen as rst-line antipsychotic therapy for patients with schizophrenia. Occasionally, the agitated child with new-onset schizophrenia may need a benzodiazepine (such as lorazepam) to calm and alleviate the anxiety accompanying the experience of psychosis. Benzodiazepines have been used in combination with antipsychotic agents early in the treatment of acute psychosis when sedation is needed. Neuroleptic malignant syndrome (NMS) is an adverse e"ect of antipsychotic drugs and is characterized by fever, muscle rigidity, and autonomic dysfunction. The syndrome has been treated with dopamine agonists, such as bromocriptine and amantadine. Other drugs used include dantrolene sodium, benztropine, and diphenhydramine. Anticholinergic drugs have been used to prevent and treat acute dystonia, parkinsonism, and NMS, as well as tardive dyskinesia. Benztropine can be started concurrently with antipsychotic drugs to prevent or control extrapyramidal reactions that occur as adverse e"ects of neuroleptic agents. In addition, beta-adrenergic blockers have been used to treat akathisia, tremor, anxiety, and aggression. Propranolol may be helpful in treating akathisia. Potential Side E"ects of Atypical Antipsychotics The use of atypical antipsychotics has been associated with metabolic changes, such as weight gain, hyperglycemia, and hyperlipidemia. Other potential side e"ects include sedation, restlessness, and extrapyramidal side e"ects such as movement disorders (e.g., tardive dyskinesia). Recommendations for monitoring adults on atypical antipsychotics include checking the following: Weight at baseline, 4, 8, and 12 weeks, and then quarterly Waist circumference at baseline and annually Blood pressure at baseline, 12 weeks, and annually Fasting plasma glucose level at baseline, 12 weeks, and annually Fasting lipid pro le at baseline, 12 weeks, and every 5 years Similar recommendations regarding atypical antipsychotics are not yet available for children and adolescents, but careful monitoring of weight, waist circumference, blood pressure, and glucose and lipids levels may be warranted. Nonpharmacologic Treatment Approaches Therapeutic interventions that appear to be helpful in bipolar disorder include family-focused therapy, interpersonal and social rhythm therapy, and cognitive-behavioral therapy. The goals of these therapies are shown in Table 1. 3
4 Table 1. Goals of Psychosocial Treatment of Pediatric Bipolar Disorder Family-focused therapy Interpersonal and social rhythm therapy Cognitive-behavioral therapy > Increased communication > Educate patient about prodromes and develop a plan to intervene > Examine beliefs about medication and adherence > Stabilize daily routines and sleep-wake cycle > Improve personal relationships and insight into moods > Track sleep, activities, and mood > Restructure dysfunctional beliefs > Monitor moods and prodromes > Intervene constructively to alter moods Psychosocial treatment of pediatric schizophrenia should include psychoeducation for the patient and the patient s family. For the patient, this involves education about the illness and treatment options, relapse prevention, basic life skills training, social skills training, and problem-solving skills training. Families must also be educated on the illness and treatment options, as well as the patient s prognosis and strategies to cope with the patient. Children with bipolar disorder or schizophrenia require multimodal care. Additional psychosocial treatments that may be indicated include special education, vocational programs, and community support with social acceptance (such as school programs). Health Plan Coverage Requirements Based on American Academy of Child and Adolescent Psychiatry (AACAP) Practice Parameters Most health plans cover treatment of pediatric bipolar disorder and schizophrenia based on practice parameters developed by the AACAP. The latest recommendations for the assessment and treatment of children and adolescents with bipolar disorder can be summarized as follows: Psysciatric assessments for children and adolescents should include screening questions for bipolar disorder Youths with suspected bipolar disorder must also be carefully evaluated for other associated problems, including suicidality, comorbid disorders (including substance abuse), psychosocial stressors, and medical problems The diagnostic validity of bipolar disorder in young children has yet to be established. Caution must be taken before applying this diagnosis in preschool children Psyschopharmacological interventions require baseline and follow-up symptom, side e"ect (including patient s weight), and laboratory monitoring as indicated Psyschotherapeutic interventions are an important component of a comprehensive treatment plan for early-onset bipolar disorder For children and adolescents with schizophrenia, the AACAP recommends the following: Psychiatric assessments for children and adolescents should include screening questions for psychosis The diagnosis of schizophrenia in children and adolescents should follow DSM-V criteria, using the same criteria as for adults Youth with suspected schizophrenia should be carefully evaluated for other pertinent clinical conditions and/or associated problems, including suicidality, comorbid disorders, substance abuse, developmental disabilities, psychosocial stressors, and medical problems Antipsychotic medication is a primary treatment for schizophrenia spectrum disorders in children and adolescents. Ongoing medication therapy should be provided to most youths with schizophrenia to improve functioning and prevent relapse Some youths with schizophrenia spectrum disorders may bene t from adjunctive medication treatments to address side e"ects of the antipsychotic agent or to alleviate associated symptomatology (such as agitation, mood instability, depression, explosive outbursts) A trial of clozapine should be considered for youths with treatment resistant schizophrenia spectrum disorders. Baseline and follow-up monitoring of symptoms, side e"ects, and laboratory tests should be performed as indicated. Psychotherapeutic interventions should be provided in combination with medication therapies 4
5 Electroconvulsive therapy may be used with severely impaired adolescents if medications either are not helpful or cannot be tolerated. Due to the speci c risks associated with the use of atypical antipsychotic agents (AAAs), the AACAP states that factors to address, prior to the initiation of treatment with the AAAs, include obtaining and documenting: target symptoms, pretreatment abnormal movements, suspected side e"ects, and the monitoring for known side e"ects; a personal and family history of diabetes and hyperlipidemia, seizures and cardiac abnormalities, as well as any family history of previous response or adverse events associated with AAAs; any required baseline and follow-up laboratory monitoring (parameters indicative of the onset of metabolic syndrome such as fasting blood sugar or hemoglobin A1C, lipid pro le, weight, and BMI); and treatment response. T The AACAP practice parameters for the use of AAAs in children and adolescents also recommend: Dosing of the AAAs should follow the start low and go slow approach and seek to nd the lowest e"ective dose, recognizing that dosing may di"er based on the targeted symptoms and patient diagnosis If side e"ects such as movement disorders or sedation do occur, a trial at a lower dose should be considered; however, certain side e"ects (e.g., NMS) may preclude further treatment with the speci c AAA The use of multiple psychotropic medications in refractory patients may, at times, be necessary but has not been studied rigorously. Clinicians should proceed with caution The acute and long-term safety of these medications in children and adolescents has not been fully evaluated; therefore careful and frequent monitoring of side e"ects should be performed A BMI measurement should be obtained at baseline and monitored at regular intervals throughout treatment with an AAA Careful attention should be given to the increased risk of developing diabetes with the use of AAA, and blood glucose levels and other parameters (clinical signs and symptoms of diabetes and hemoglobin A1C) should be obtained at baseline and monitored at regular intervals In those patients with signi cant weight changes and/or a family history indicating high risk, lipid pro les should be obtained at baseline and monitored at regular intervals Measurements of movement disorders utilizing structured measures, such as the Abnormal Involuntary Movement Scale, should be done at baseline and at regular intervals during treatment and during tapering of the AAA Due to limited data surrounding the impact of AAAs on the cardiovascular system, regular monitoring of heart rate, blood pressure and EKG changes should be performed Although there is a relationship between AAA use and elevations of prolactin, the current state of evidence does not support the need for routine monitoring of prolactin levels in asymptomatic youths Due to drug-speci c risks, additional monitoring should be considered for speci c AAAs o Clozapine may be associated with agranulocytosis and neutropenia, may lower the seizure threshold, and may cause substantial weight gain o Hematological monitoring, pre-treatment EEG and a comparison EEG when optimal drug levels have been achieved, and monitoring of liver enzymes should be conducted. o Quetiapine may increase risk of cataract formation. Baseline ophthalmologic examination with periodic o re-assessment should be conducted. Ziprasidone may increase risk of QTc changes An EKG at baseline and once a stable dose is achieved should be conducted. The limited long-term safety and e!cacy data warrants careful consideration, before the initiation of medication, of the planned duration of the medication trial Abrupt discontinuation of a medication is not recommended 5
6 The Role of External Independent Medical Review in Determining Medical Necessity for Treatment of Pediatric Bipolar Disorder and Schizophrenia Safe and e"ective treatment of pediatric patients with bipolar disorder and schizophrenia has become increasingly complex due to more common use of atypical antipsychotic agents in children and adolescents. An independent medical review, which is normally used by healthcare payers, looks at whether or not a speci c therapy or procedure was medically necessary. Healthcare plans may lack board-certi ed specialists internally. Independent review organizations (IROs) allow ready access to a range of board-certi ed physician specialists. The specialists who review cases for IROs keep up-to-date with the latest medical research literature and with the latest standard of care, staying on top of continually evolving therapies as they are studied more extensively and potentially accepted into clinical guidelines. Conclusion Accurate diagnoses of bipolar disorder and schizophrenia in children, which pose many challenges, are critical not only due to the importance of timely treatment, but also because of the risks associated with over-diagnosing and stigmatizing children. While studies have shown that medications are e"ective for the treatment of young patients with these disorders, a comprehensive treatment approach ideally consists of both pharmacologic and non-pharmacologic options in order to allow for optimal care while meeting the unique needs of individual patients. Bibliography American Academy of Child and Adolescent Psychiatry. Practice parameter for the use of atypical antipsychotic medications in children and adolescents. Available at: Atypical_Antipsychotic_Medications_Web.pdf. Accessed December 1, American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, Va: American Psychiatric Publishing; May McClellan J, Kowatch R, Findling RL; Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2007;46: McClellan J, Stock S; American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI). Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry. 2013;52: Moreno C, Laje G, Blanco C, Jiang H, Schmidt AB, Olfson M. National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Arch Gen Psychiatry. 2007;64: About AllMed AllMed Healthcare Management provides physician review outsourcing solutions to leading health plans, medical management organizations, TPAs and integrated health systems, nationwide. AllMed o"ers MedReview (SM), MedCert (SM), and Medical Director sta!ng services that cover initial pre-authorizations and both internal and external appeals, drawing on a panel of over 400 board-certi ed specialists in all areas of medicine. Services are deployed through PeerPoint, AllMed s state-of-the-art medical review portal. For more information on how AllMed can help your organization improve the quality and integrity of healthcare, contact us today at info@allmedmd.com or visit us at 621 SW Alder St., Suite 740 Portland, OR
Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder,
Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder, Journal of the Academy of Child and Adolescent Psychiatry, 1997 Primary Authors: Jon McClellan MD
More informationDSM5: How to Understand It and How to Help
DSM5: How to Understand It and How to Help Introduction: The DSM5 is a foreign language! Three Questions: I. The first was, What the key assumptions made to determine the organization of the DSM5? A. Mental
More informationCASE 5 - Toy & Klamen CASE FILES: Psychiatry
CASE 5 - Toy & Klamen CASE FILES: Psychiatry A 14-year-old boy is brought to the emergency department after being found in the basement of his home by his parents during the middle of a school day. The
More informationEARLY ONSET SCHIZOPHRENIA
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences EARLY ONSET SCHIZOPHRENIA JON MCCLELLAN CHILD STUDY AND TREATMENT CENTER GENERAL DISCLOSURES The University of Washington
More informationBipolar Disorder in Youth
Bipolar Disorder in Youth Janet Wozniak, M.D. Associate Professor of Psychiatry Director, Pediatric Bipolar Disorder Research Program Harvard Medical School Massachusetts General Hospital Pediatric-Onset
More informationUpdate on First Psychotic Episodes in Childhood and Adolescence. Cheryl Corcoran, MD Assistant Professor of Psychiatry Columbia University
Update on First Psychotic Episodes in Childhood and Adolescence Cheryl Corcoran, MD Assistant Professor of Psychiatry Columbia University Childhood-Onset Psychosis 8% of psychiatrically referred youth
More informationElements for a Public Summary. VI.2.1 Overview of disease epidemiology
VI.2 Elements for a Public Summary VI.2.1 Overview of disease epidemiology Schizophrenia Schizophrenia is a mental disorder often characterized by abnormal social behaviour and failure to recognize what
More informationDEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.
DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. Introduction. Parkinson's disease (PD) has been considered largely as a motor disorder. It has been increasingly recognized that
More informationKelly Godecke, MD Department of Psychiatry University of Utah
Kelly Godecke, MD Department of Psychiatry University of Utah Epidemiology and Impact -module 2 session 1 overview of mood disorders Diagnostic Criteria of Bipolar Disorders Medications Used in Bipolar
More informationACOEM Commercial Driver Medical Examiner Training Program
ACOEM Commercial Driver Medical Examiner Training Program Module 7: Psychological Psychological 49 CFR 391.41(b)(9) "A person is physically qualified to drive a commercial motor vehicle if that person
More informationComprehensive Quick Reference Handout on Pediatric Bipolar Disorder By Jessica Tomasula
Comprehensive Quick Reference Handout on Pediatric Bipolar Disorder By Jessica Tomasula Official Name Bipolar Disorder; also referred to as Manic Depression Definitions (DSM-IV-TR, 2000) Bipolar I Disorder
More informationMedication Audit Checklist- Antipsychotics - Atypical
Medication Audit checklist Page 1 of 7 10-2018 Audit number: Client number: Ordering Provider: INDICATIONS 1) Disorders with psychotic symptoms (schizophrenia, schizoaffective disorder, manic disorders,
More informationPreferred Practice Guidelines Bipolar Disorder in Children and Adolescents
BadgerCare Plus Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents These Guidelines are based in part on the following: American Academy of Child and Adolescent Psychiatry s Practice
More informationChoosing Wisely Psychiatry s Top Priorities for Appropriate Primary Care
Choosing Wisely Psychiatry s Top Priorities for Appropriate Primary Care JASON BEAMAN D.O., M.S., FAPA ASSISTANT CLINICAL PROFESSOR CHAIR, DEPARTMENT OF PSYCHIATRY AND BEHAVIORAL SCIENCES OKLAHOMA STATE
More informationMedications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation
Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral
More informationBrief Notes on the Mental Health of Children and Adolescents
Brief Notes on the Mental Health of Children and Adolescents The future of our country depends on the mental health and strength of our young people. However, many children have mental health problems
More informationCondensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia
Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia I. Key Points a. Schizophrenia is a chronic illness affecting all aspects of person s life i. Treatment Planning Goals 1.
More informationPsychotic disorders Dr. Sarah DeLeon, MD PGYIV, Psychiatry ConceptsInPsychiatry.com
Psychotic disorders Dr. Sarah DeLeon, MD PGYIV, Psychiatry ConceptsInPsychiatry.com Introduction Psychotic spectrum disorders include schizotypal personality disorder, delusional disorder, brief psychotic
More informationDisclosure Statement. A Rational Approach to Psychopharmacology. Goals 10/28/2013
A Rational Approach to Psychopharmacology Disclosure Statement Full time employed physician with MaineGeneral Medical Center in Waterville and Augusta No conflicts of interest to disclose Goals Promote
More informationAre All Older Adults Depressed? Common Mental Health Disorders in Older Adults
Are All Older Adults Depressed? Common Mental Health Disorders in Older Adults Cherie Simpson, PhD, APRN, CNS-BC Myth vs Fact All old people get depressed. Depression in late life is more enduring and
More information3/9/2017. A module within the 8 hour Responding to Crisis Course. Our purpose
A module within the 8 hour Responding to Crisis Course Our purpose 1 What is mental Illness Definition of Mental Illness A syndrome characterized by clinically significant disturbance in an individual
More informationAntipsychotic Use in the Elderly
Antipsychotic Use in the Elderly Presented by: Fatima M. Ali, PharmD, RPh, BCPS Clinical Consultant Pharmacist MediSystem Pharmacy, Kingston Originally Prepared by: Nicole Tisi BScPhm, RPh ACPR Disclosure
More informationPharmacotherapy of psychosis and schizophrenia in youth
Pharmacotherapy of psychosis and schizophrenia in youth Benedetto Vitiello Pavia, 2 December 2017 Disclosure Benedetto Vitiello, M.D. Professor of Child and Adolescent Neuropsychiatry University of Turin,
More informationBIPOLAR DISORDER AND ADHD IN CHILDREN
BIPOLAR DISORDER AND ADHD IN CHILDREN BIPOLAR I DISORDER IS BEING DIAGNOSED WITH INCREASING FREQUENCY (INTENSITY) IN PRE-PUBERTAL CHIDREN WITH THE CAVEAT (WARNING / STIPULATION) THAT CLASSIC MANIC EPISODES
More informationVI.2 Elements for a public summary. VI.2.1 Overview of disease epidemiology
VI.2 Elements for a public summary VI.2.1 Overview of disease epidemiology Incidence and prevalence of target indication Schizophrenia is a mental disorder characterized by a breakdown of thought processes
More informationPromoting and Monitoring Evidenced-Based Antipsychotic Prescribing Practices in Children and Adolescents: Florida Medicaid Initiatives
Promoting and Monitoring Evidenced-Based Antipsychotic Prescribing Practices in Children and Adolescents: Florida Medicaid Initiatives Mary Elizabeth Jones, Pharm BSc, RPh Senior Pharmacist AHCA Pharmacy
More informationTreatment Options for Bipolar Disorder Contents
Keeping Your Balance Treatment Options for Bipolar Disorder Contents Medication Treatment for Bipolar Disorder 2 Page Medication Record 5 Psychosocial Treatments for Bipolar Disorder 6 Module Summary 8
More informationSummary of the risk management plan (RMP) for Aripiprazole Mylan Pharma (aripiprazole)
EMA/370707/2016 Summary of the risk management plan (RMP) for Aripiprazole Mylan Pharma (aripiprazole) This is a summary of the risk management plan (RMP) for Aripiprazole Mylan Pharma, which details the
More informationHealthyPlace s Introductory Guide to Bipolar Disorder. By Natasha Tracy
HealthyPlace s Introductory Guide to Bipolar Disorder By Natasha Tracy 1 Index Introduction Chapter One Bipolar Disorder Basics Chapter Two Bipolar Disorder Diagnosis Chapter Three Treatment of Bipolar
More informationDepressive and Bipolar Disorders
Depressive and Bipolar Disorders Symptoms Associated with Depressive and Bipolar Disorders Characteristics of mood symptoms Affects a person s well being, school, work, or social functioning Continues
More informationBipolar Disorder Clinical Practice Guideline Summary for Primary Care
Bipolar Disorder Clinical Practice Guideline Summary for Primary Care DIAGNOSIS AND CLINICAL ASSESSMENT Bipolar Disorder is categorized by extreme mood cycling; manifested by periods of euphoria, grandiosity,
More informationSECTION 1. Children and Adolescents with Depressive Disorder: Summary of Findings. from the Literature and Clinical Consultation in Ontario
SECTION 1 Children and Adolescents with Depressive Disorder: Summary of Findings from the Literature and Clinical Consultation in Ontario Children's Mental Health Ontario Children and Adolescents with
More informationPRESCRIBING GUIDELINES
The Maudsley The South London and Maudsley NHS Foundation Trust & Oxleas NHS Foundation Trust PRESCRIBING GUIDELINES 10th Edition David Taylor Carol Paton Shitij Kapur informa healthcare Contents Authors
More informationPrimary Care: Referring to Psychiatry
Primary Care: Referring to Psychiatry Carol Capitano, PhD, APRN-BC Assistant Professor, Clinical Educator University of New Mexico College of Nursing University of New Mexico Psychiatric Center Objectives
More informationJonathan Haverkampf BIPOLAR DISORDR BIPOLAR DISORDER. Dr. Jonathan Haverkampf, M.D.
BIPOLAR DISORDER Dr., M.D. Abstract - Bipolar disorder is a condition affecting an individual s affective states (mood). The different flavors of bipolar disorder have in common that there are alterations
More informationDIAN KUANG 馬 萬. Giovanni Maciocia
DIAN KUANG 癫狂 馬 萬 Giovanni Maciocia 里 BIPOLAR DISORDER (MANIC-DEPRESSION) DIAN Qi and Phlegm stagnating Heart and Spleen deficiency with Phlegm Qi deficiency with Phlegm KUANG Phlegm-Fire harassing upwards
More informationThe Mental Health of People with Prader- Willi Syndrome with Specific Focus on Mood Disorders and Psychotic Illness
The Mental Health of People with Prader- Willi Syndrome with Specific Focus on Mood Disorders and Psychotic Illness By Tony Holland B.Sc., M.B.B.S., M.R.C.P., M.Phil., F.R.C.Psych., Emeritus Professor
More informationPsychotic Disorders in Children and Adolescents
Psychotic Disorders in Children and Adolescents Dr. Marcelo Rodriguez-Chevres, M.D. Emergence Health Network Learning Objectives Audience will be able to: 1. Distinguish developmentally normal experiences
More informationClass Update: Oral Antipsychotics
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationAutism. Childhood Autism and Schizophrenia. Autism, Part 1 Diagnostic Criteria (DSM-IV-TR) Behavioral Characteristics of Autism
Autism Childhood Autism and Dr. K. A. Korb University of Jos Autism comes from the Latin within oneself Autism: Severe developmental disorder characterized by abnormalities in: Social functioning Language
More informationIndex. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers
Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) a-adrenergic blockers for PTSD, 798 b-adrenergic blockers for PTSD, 798 Adrenergic
More informationElements for a Public Summary
VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Schizophrenia Schizophrenia is a mental illness with a number of symptoms, including confused or unclear thinking and speech,
More informationMood Disorders for Care Coordinators
Mood Disorders for Care Coordinators David A Harrison, MD, PhD Assistant Professor, Dept of Psychiatry & Behavioral Sciences University of Washington School of Medicine Introduction 1 of 3 Mood disorders
More informationBipolar Disorder 4/6/2014. Bipolar Disorder. Symptoms of Depression. Mania. Depression
Bipolar Disorder J. H. Atkinson, M.D. Professor of Psychiatry HIV Neurobehavioral Research Programs University of California, San Diego KETHEA, Athens Slides courtesy of John Kelsoe, M.D. Bipolar Disorder
More informationEU Risk Management Plan
6.2 Elements for Public Summary - Abilify 6.2.1 Overview of Disease Epidemiology Bipolar I Disorder Reported prevalence rates for bipolar I disorder differ due to local variations in psychiatric practice,
More informationENTITLEMENT ELIGIBILITY GUIDELINE SCHIZOPHRENIA
Entitlement Eligibility Guideline SCHIZOPHRENIA Page 1 of 8 ENTITLEMENT ELIGIBILITY GUIDELINE SCHIZOPHRENIA MPC 00607 ICD-9 295 ICD-10 F20 DEFINITION SCHIZOPHRENIA Characteristic symptoms of Schizophrenia
More informationClinical Guideline for the Management of Bipolar Disorder in Adults
Clinical Guideline for the Management of Bipolar Disorder in Adults Goal: To improve the quality of life of adults with bipolar disorder Identification and Treatment of Bipolar Disorder Criteria for Diagnosis:
More informationChapter 161 Antipsychotics
Chapter 161 Antipsychotics Episode Overview Extrapyramidal syndromes are a common complication of antipsychotic medications. First line treatment is benztropine or diphenhydramine. Lorazepam is used in
More informationDrugs for Emotional and Mood Disorders Chapter 16
Drugs for Emotional and Mood Disorders Chapter 16 NCLEX-RN Review Question 1 Choices Please note Question #1 at the end of Ch 16 pg 202 & Key pg 805 answer is #4 1. Psychomotor symptoms 2. Tachycardia,
More informationPsychosis and Agitation in Dementia
Psychosis and Agitation in Dementia Dilip V. Jeste, MD Estelle & Edgar Levi Chair in Aging, Director, Stein Institute for Research on Aging, Distinguished Professor of Psychiatry & Neurosciences, University
More informationYour journal: how can it help you?
Journal Your journal: how can it help you? By monitoring your mood along with other symptoms like sleep, you and your treatment team will be better able to follow the evolution of your symptoms and therefore
More informationCOURSES ARTICLE - THERAPYTOOLS.US
COURSES ARTICLE - THERAPYTOOLS.US Individual Planning: A Treatment Plan Overview for with Individuals Hypomania and Mania in Bipolar Disorder Control Problems. Individual Planning: A Treatment Plan Overview
More informationTreatment of Schizophrenia
Treatment of Schizophrenia Conduct comprehensive assessment and use measurement-based care as found in the Principles of Practice (review pages 4-7). Most importantly assess social support system (housing,
More informationBLONANSERIN. THERAPEUTICS Brands Lonasen see index for additional brand names
BLONANSERIN THERAPEUTICS Brands Lonasen see index for additional brand names Generic? No Class Atypical antipsychotic (serotonin dopamine antagonist; second-generation antipsychotic; also a potential mood
More informationWhen is a Psychological Disorder a Disability? Dr. Leigh Ann Ford, PhD, HSP Licensed Psychologist ABVE 2017 Annual Conference. Goals for presentation
When is a Psychological Disorder a Disability? Dr. Leigh Ann Ford, PhD, HSP Licensed Psychologist ABVE 2017 Annual Conference Goals for presentation *To review DSM-V criteria for some of the most frequently
More informationPsychiatric Medications. Positive and negative effects in the classroom
Psychiatric Medications Positive and negative effects in the classroom Teaching the Medicated Child Beverly Bryant, M.D. Hattiesburg Clinic 9/17/14 Introduction According to the National Survey of Children
More informationCrisis Intervention Team (CIT) Training
Crisis Intervention Team (CIT) Training Student Guide Bipolar Disorder Created by: Nils Rosenbaum Matthew Tinney Lawrence Saavedra Bipolar Disorder What is bipolar disorder? Bipolar disorder is a brain
More informationTHIOTHIXENE. THERAPEUTICS Brands Navane see index for additional brand names. Generic? Yes
THIOTHIXENE THERAPEUTICS Brands Navane see index for additional brand names Generic? Yes Class Conventional antipsychotic (neuroleptic, thioxanthene, dopamine 2 antagonist) Commonly Prescribed for (bold
More informationPsychotropic Medication. Including Role of Gradual Dose Reductions
Psychotropic Medication Including Role of Gradual Dose Reductions What are they? The phrase psychotropic drugs is a technical term for psychiatric medicines that alter chemical levels in the brain which
More informationAccurate Diagnosis of Primary Psychotic Disorders
Accurate Diagnosis of Primary Psychotic Disorders The Care Transitions Network National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State Office of Mental Health Netsmart
More informationFL Medicaid Drug Therapy Management Program for Behavioral Health Monitoring for Safety and Quality
FL Medicaid Drug Therapy Management Program for Behavioral Health Monitoring for Safety and Quality April 23, 2014 Pensacola, FL Presentation Objectives To briefly describe the program and how its components
More informationAnnouncements. The final Aplia gauntlet: Final Exam is May 14, 3:30 pm Still more experiments going up daily! Enhanced Grade-query Tool+
The final Aplia gauntlet: Announcements Chapter 12 Aplia due tonight Chapter 13 Aplia due Wednesday Final Exam is May 14, 3:30 pm Still more experiments going up daily! Enhanced Grade-query Tool+ Now includes
More informationDepressive, Bipolar and Related Disorders
Depressive, Bipolar and Related Disorders Robert Kelly, MD Assistant Professor of Psychiatry Weill Cornell Medical College White Plains, New York Lecture available at www.robertkelly.us Financial Conflicts
More informationAggression (Severe) in Children under Age 6
Aggression (Severe) in Children under Age 6 Level 0 Comprehensive diagnostic assessments. Refer to Principles of Practice on page 6. Evaluate and treat comorbid conditions (i.e. medical, other psychiatric
More informationDifferentiating Unipolar vs Bipolar Depression in Children
Differentiating Unipolar vs Bipolar Depression in Children Mai Uchida, M.D. Director, Center for Early Identification and Prevention of Pediatric Depression Massachusetts General Hospital Assistant Professor
More informationPresented by Bevan Gibson Southern IL Professional Development Center -Part of the Illinois Community College Board Service Center Network
Bipolar Disorder: What It Means to You and Your Classroom Presented by Bevan Gibson Southern IL Professional Development Center -Part of the Illinois Community College Board Service Center Network Introduction
More informationa build up of acid in your blood due to ketones (ketoacidosis) coma death
MEDICATION GUIDE OLANZAPINE ORALLY DISINTEGRATING TABLETS, USP (oh lan za peen) 5 mg, 10 mg, 15 mg and 20 mg Read the Medication Guide that comes with olanzapine orally disintegrating tablets before you
More informationMood disorders. Carolyn R. Fallahi, Ph. D.
Mood disorders Carolyn R. Fallahi, Ph. D. Childhood bipolar disorder Dramatic mood swings Occur in cycles Exhilaration and agitation = mania Depression Normal mood The typical adult cycle How do children
More informationBipolar Disorders. Disclosure Statement. I have no financial disclosures or conflicts of interest
Bipolar Disorders Ahsan Naseem, MD Diplomate American Board of Psychiatry and Neurology Adult and Geriatric Psychiatry Medical Director Bryan Heartland Psychiatry Bryan Physician Network Partner Cheney
More informationPiecing the Puzzle Together: Pharmacologic Approaches to Behavioral Management in Autism Spectrum Disorder
Piecing the Puzzle Together: Pharmacologic Approaches to Behavioral Management in Autism Spectrum Disorder Hannah Sauer, PharmD PGY1 Pediatric Pharmacy Resident Mayo Clinic 2015 MFMER slide-1 Objectives
More informationThe alternate reality of schizophrenia
The alternate reality of schizophrenia MICHAEL TRINSEY SCHIZOPHRENIA IS A GROUP of chronic, disabling psychiatric disorders characterized by disturbed thinking and disorganized speech. Patients with schizophrenia
More informationForty-Eighth Annual Teaching Conference Pediatrics for the Practitioner -UT Health Science Center San Antonio School of Medicine June 10-12, 2011
Adelaide Robb, MD Associate Professor Psychiatry and Pediatrics Source Advisory Board Disclosure Speaker s Bureau Bristol Myers Squibb Yes Yes Yes Epocrates Research Contract Royalties Yes Stock Janssen
More information6/22/2012. Co-morbidity - when two or more conditions occur together. The two conditions may or may not be causally related.
Autism Spectrum Disorders and Co-existing Mental Health Issues By Dr. Karen Berkman Objective To present an overview of common psychiatric conditions that occur in persons with autism spectrum disorders
More informationKey Issues in Child Welfare: Behavioral Health (abridged elearning Storyboard)
Key Issues in Child Welfare: Behavioral Health (abridged elearning Storyboard) We ve covered the key issues of substance use disorders and intimate partner violence. Let s talk now about behavioral health.
More informationDiagnosis and treatment of acute agitation and aggression in patients with schizophrenia and bipolar disorder: evidence for the efficacy of atypical
Diagnosis and treatment of acute agitation and aggression in patients with schizophrenia and bipolar disorder: evidence for the efficacy of atypical antipsychotics 1 Abstract Acute agitation and aggression
More informationUse of Psychotherapeutic Medications in Children and Adolescents with ASD and ID
Use of Psychotherapeutic Medications in Children and Adolescents with ASD and ID Although not considered first line treatment in children with ASD and ID, depending on the severity of symptoms, some medications
More informationCHAPTER 3. Schizophrenia and Antipsychotic Treatment
CHAPTER 3 Schizophrenia and Antipsychotic Treatment What is it? It is a severe, chronic, disabling brain disease Considered to have biological origins but exact unknown 1% of population affected Schizophrenia
More informationChapter 12 1/29/2018. Schizophrenia and Schizophrenia Spectrum Disorders. Epidemiology. Comorbidity. Lifetime prevalence of schizophrenia is 1%
Chapter 12 Schizophrenia and Schizophrenia Spectrum Disorders Epidemiology Lifetime prevalence of schizophrenia is 1% No difference related to 2 Comorbidity Substance abuse disorders Anxiety, depression,
More informationMajor Depressive Disorder (MDD) in Children under Age 6
in Children under Age 6 Level 0 Comprehensive assessment. Refer to Principles of Practice on page 5. Level 1 Psychotherapeutic intervention (e.g., dyadic therapy) for 6 to 9 months; assessment of parent/guardian
More informationMEDICATION GUIDE Quetiapine Fumarate Tablets
MEDICATION GUIDE Quetiapine Fumarate Tablets Read this Medication Guide before you start taking quetiapine fumarate tablets and each time you get a refill. There may be new information. This Medication
More informationPsychosis. Paula Gibbs, MD Department of Psychiatry University of Utah
Psychosis Paula Gibbs, MD Department of Psychiatry University of Utah Psychotic Symptoms Psychosis in a broad sense, signifies impaired reality testing ability Symptoms include: hallucinations, delusions,
More informationAffective Disorders.
Affective Disorders http://www.bristol.ac.uk/medicalschool/hippocrates/psychethics/ Affective Disorders Depression Mania / Hypomania Bipolar mood disorder Recurrent depression Persistent mood disorders
More informationMEDICATION GUIDE. Quetiapine (kwe-tye-a-peen) Tablets USP
MEDICATION GUIDE Quetiapine (kwe-tye-a-peen) Tablets USP Read this Medication Guide before you start taking quetiapine tablets and each time you get a refill. There may be new information. This information
More informationOhio Psychotropic Medication Quality Improvement Collaborative. Minds Matter. Toolkit. for You and Your Family. This is the property of
Minds Matter Ohio Psychotropic Medication Quality Improvement Collaborative Minds Matter Toolkit for You and Your Family This is the property of About Minds Matter Minds Matter is a project to help teens,
More informationAlcoholism. Psychiatry. Alcoholism. Alcoholism. Certification. Certification
Alcoholism Psychiatry Liz Clark, D.O., MPH & TM FAOCOPM MY-2012 Except where absolute criteria exist (i.e., a current clinical diagnosis of alcoholism), as a medical examiner, you make the final determination
More informationReview Session 3. Case. Annemarie Mikowski DO Assistant Clinical Instructor Chief Resident Psychiatry
Review Session 3 Annemarie Mikowski DO Assistant Clinical Instructor Chief Resident Psychiatry Case A 26 y/o F describes difficulty sleeping. She has been feeling steadily overwhelmed and anxious at her
More informationCHILD AND ADOLESCENT ISSUES BEHAVIORAL HEALTH. SAP K-12 Bridge Training Module for Standard 4 Section 3: Behavioral Health & Observable Behaviors
CHILD AND ADOLESCENT BEHAVIORAL HEALTH ISSUES SAP K-12 Bridge Training Module for Standard 4 Section 3: Behavioral Health & Observable Behaviors MODULE 4: SECTION 34: SECTION 3 4.b. Articulate the school
More informationHealthPartners Care Coordination Clinical Care Planning and Resource Guide MENTAL HEALTH
The following Evidence Base Guideline was used in developing this clinical care guide: MCG Behavioral Health Guidelines and National Institute of Mental Health (NIMH). Documented Health Conditions: Depression
More informationGOALS FOR THE PSCYHIATRY CLERKSHIP
GOALS FOR THE PSCYHIATRY CLERKSHIP GOALS - The aim of the core psychiatry clerkship is to expose students to patients with mental illness and to prepare them to provide psychiatric care at a basic level.
More informationIn 2020 mental and substance use disorders will surpass all physical diseases as a major cause of disability worldwide
1 In 2020 mental and substance use disorders will surpass all physical diseases as a major cause of disability worldwide 2 Incidence of Mental Illness 10-25% of general population 6% experience serious
More informationCHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XV, 2013 INDEX
A acceptance and commitment therapy Posttraumatic Stress, 69 ADHD Adjunctive Fatty Acids, 5 Adjunctive Guanfacine Pharmacokinetics, 27 Amantadine, 21 Atomoxetine, 23 Cancer Risk, 31 CBT for Comorbid Anxiety,
More informationPSYCH 335 Psychological Disorders
PSYCH 335 Psychological Disorders Chapter 10 Schizophrenia and Psychotic Disorders Outline/Overview Schizophrenia Statistics/Impact/History Criteria Prognostic indicators/ suicide Epidemiology/correlates
More information4/29/2016. Psychosis A final common pathway. Early Intervention in Psychotic Disorders: Necessary, Effective, and Overdue
Early Intervention in Psychotic Disorders: Necessary, Effective, and Overdue Disclosures Financial relationships with commercial interests Douglas R. Robbins, M.D. Maine Medical Center Tufts University
More information4. Definition, clinical diagnosis and diagnostic criteria
4. Definition, clinical diagnosis and diagnostic criteria 4.1. Definition Major depression is a mood disorder consisting of a set of symptoms, which include a predominance of the affective type (pathological
More informationPractical Considerations Related to Pharmacology and Developmental Disabilities
Practical Considerations Related to Pharmacology and Developmental Disabilities Dr. Eileen Trigoboff RN, PMHCNS-BC, DNS, DABFN 1 Outline Common presentations of DD Assessment strategies with individuals
More informationContemporary Psychiatric-Mental Health Nursing Third Edition. Introduction. Introduction 9/10/ % of US suffers from Mood Disorders
Contemporary Psychiatric-Mental Health Nursing Third Edition CHAPTER 17 Mood Disorders Introduction 12% of US suffers from Mood Disorders MD are a group of psychiatric DO characterized by physical, emotional
More informationSchizophrenia. Introduction. Overview and Facts
Introduction is a chronic, severe and disabling brain disease that typically shows its first clear symptoms in late adolescence or early adulthood. It is one of several types of Psychotic Disorders. It
More informationThings You Might Not Know About Psychotropic Medications But Wish You Did
Things You Might Not Know About Psychotropic Medications But Wish You Did John E. Dunne, MD December 3, 2016 PAL Conference Conflicts of Interest None to report I am employed by Seattle Children s and
More information